4-(1,3-dioxolan-2-yl)-4'-thiomethylbenzophenone, 97.0%, 1g

5-[(2-ethyl-6-methylphenyl)amino]-2,3-dihydro-1,3,4-thiadiazole-2-thione, 97%, 250mg

4,4'-Dihydroxy-[1,1'-biphenyl]-3,3'-dicarbaldehyde, 97%, 1g

tert-Butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5H)-carboxylate, 95.0%, 1g

6-benzilamminopurina, minimo 98%, per biochimica, 1 g, confezione in vetro

2-Chloro-4-fluoro-5-nitrobenzoic acid, 97.0%, 5g

1-[(4R)-4-(Phenylmethyl)-2-thioxo-3-oxazolidinyl]-1-propanone, 97%, 250mg

2-{8-[(tert-Butoxy)carbonyl]-1-oxa-8-azaspiro[4.5]decan-3-yl}acetic acid, 98+%, 1g

Diethyl Oxalacetate>95.0%(GC)5g

7,8-Dihydroxy-2-phenyl-4H-chromen-4-one, 95.0%, 250mg

2-(Bromomethyl)-1,3-dichlorobenzene, 97.0%, 10g

(3-Trifluoromethyl-1H-pyrazol-4-yl)methanol, 95.0%, 1g

5-CHLORO-3-(2-NITROVINYL)-1H-INDOLE, 95.0%, 1g